nedosiran
General
Pronunciation:
ned-oh-sir-an
Trade Name(s)
- Rivfloza
Ther. Class.
none assigned
Pharm. Class.
small interfering ribonucleic acid agents
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., et al. "Nedosiran." Davis's Drug Guide, 19th ed., F.A. Davis Company, 2025. Anesthesia Central, anesth.unboundmedicine.com/anesthesia/view/Davis-Drug-Guide/3580069/all/nedosiran.
Vallerand AHA, Sanoski CAC, . Nedosiran. Davis's Drug Guide. F.A. Davis Company; 2025. https://anesth.unboundmedicine.com/anesthesia/view/Davis-Drug-Guide/3580069/all/nedosiran. Accessed April 22, 2025.
Vallerand, A. H., Sanoski, C. A., & , (2025). Nedosiran. In Davis's Drug Guide (19th ed.). F.A. Davis Company. https://anesth.unboundmedicine.com/anesthesia/view/Davis-Drug-Guide/3580069/all/nedosiran
Vallerand AHA, Sanoski CAC, . Nedosiran [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2025. [cited 2025 April 22]. Available from: https://anesth.unboundmedicine.com/anesthesia/view/Davis-Drug-Guide/3580069/all/nedosiran.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - nedosiran
ID - 3580069
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
AU - ,,
BT - Davis's Drug Guide
UR - https://anesth.unboundmedicine.com/anesthesia/view/Davis-Drug-Guide/3580069/all/nedosiran
PB - F.A. Davis Company
ET - 19
DB - Anesthesia Central
DP - Unbound Medicine
ER -